Navigation Links
Official Launch of ABLE TO CHOOSE Public Awareness Campaign
Date:2/9/2009

delivering lunch to legislators, consisting of a menu with only one choice, item #46, representing Virginia's standing as 46th among all states for community-based services for people with disabilities. The day's events, along with the launch as a whole, are designed to inspire the Commonwealth, the media, and the general public to learn more about the importance of ensuring availability of community supports that make us all "able to choose" how we live.

"The ABLE TO CHOOSE campaign will demonstrate that people with disabilities of all types can and do live successfully in communities of their own choice when individually appropriate services and supports are available to them," said Lisbet Ward, Chair of the Virginia Board for People with Disabilities.

www.abletochoose.org


'/>"/>
SOURCE ABLE TO CHOOSE
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Quadra Cuts the Official Weight Loss Product of Max Muscle Sports Nutrition $25,000 MaxFormation Life Challenge
2. Case Western Reserve University School of Dental Medicine is Site for Ohio Dental Associations Give Kids a Smile State Kick-Off Program ... Legislators, Health Officials, Special Dignitaries to Attend Childrens Free Dental Care Program
3. Former FDA Official Steven Niedelman Joins Crowell & Moring Health Care Group
4. Salmonella Outbreak Plant Shipped Dubious Product Before: U.S. Health Officials
5. Five Former USAID Officials Ask Obama for Leadership on Family Planning
6. Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries
7. Officials Still Seek Source of Salmonella Outbreak
8. Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO
9. AHP Recession Survey of Nonprofit Health Care Officials Finds Almost Half Expect Reduced Giving in 2009, Leading to Cuts in Hospital Construction and Equipment Purchases
10. Cargill Receives Official Notification From FDA Supporting the Safety of Truvia(TM) Rebiana
11. Neurological & Orthopedic Named Official Hospital of Chicago Red Stars Womens Pro Soccer Team
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2
Other Medicine Technology:Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5